Catenacci, DVT, Park, H, Uronis, HE, Kang, Y-K, Ng, M, Gold, P, Lacy, J, Enzinger, PC, Park, S, Lee, K-W, Yen, J, Odegaard, J, Franovic, A, Baughman, J, Muth, J, Wynter-Horton, A, Wu, T, Wigginton, J, Davidson-Moncada, JK, and Bang, Y-J. "Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER21 gastric adenocarcinoma (GEA)." 43rd ESMO Congress (ESMO). Munich, GERMANY. October 19, 2018 - October 23, 2018.: OXFORD UNIV PRESS, October 1, 2018.